| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |